Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.78 USD | +1.52% | +7.64% | +5.44% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |